Outcome Measures
The primary outcome was the number of psychiatric medications for PSVT
patients pre- and 3 months post-ablation. Patients that were prescribed
psychiatric medications were followed to examine the difference in
number of medications at 3 months post-ablation. Medications evaluated
were serotonin selective reuptake inhibitors (SSRIs),
serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines
(BZDs), anxiolytics, antipsychotics, tricyclic antidepressants,
buspirone, trazadone, and bupropion.